Enter your login e-mail to the account
Search
- Escitalopram: new clinical findings
prof. MUDr. Jiří Horáček, Ph.D.
(2/2013, Psychopharmacology )
- The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - Follow-up after treatment in patients with malignant disease
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Andrej Rosík, MUDr. Miroslava Stratená, MUDr. Mário Bôžik
(3/2015, Main topic ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Significance of neoadjuvant treatment in patients with early breast cancer – perspective of surgeon
MUDr. Marián Karaba, prof. MUDr. Juraj Benca, PhD., MPH, MUDr. Terézia Lauková, doc. MUDr. Daniel Pinďák, PhD., MUDr. Dominika Rusnáková, MUDr. Martina Vranovská, MUDr. Otília Osifová
(2/2017, Review articles ) - Phylloid tumor
doc. MUDr. Vladimír Bella, PhD., MUDr. Lucia Bellová
(5/2011, Review articles ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Early prostate cancer: particularities of treatment
Doc. MUDr. Frederico Goncalves, PhD.
(1/2017, Review articles ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - BREAST CANCER RECIDIVES – OUR EXPERIENCES WITHIN THE YEAR 1990 – 2004
MUDr. Vladimír Bella, PhD., MUDr. Erika Zámečníková
(6/2007, Original articles ) - Management ovarian brain metastasis
MUDr. Marián Streško
(3/2009, Original articles & case reports ) - SEKCAMA 2009
MUDr. Vladimír Bella, PhD., MUDr. Dušan Malatin
(3/2009, Events )